Novo Nordisk Signs $2 Billion Deal for Experimental Obesity Drug
Novo Nordisk agreed to pay up to $2 billion for the rights to a developmental weight-loss and obesity drug from Chinese ...
Reform prior authorization. Don't eliminate it. | Letters
Prior authorization is one of the few tools to keep health care costs in check, ensuring that treatments are medically ...